We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Felix. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S (NVO)’s share was trading at $64.49 as of ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

Douglas McIntyre, Editor-in-Chief at Climate Crisis 24/7, reports that the city of Ann Arbor, Michigan, is exploring the ...

The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...

The Strategy trailed its core benchmark but bested its growth index, supported by strength among communication services and ...

The new hospital, officially named the Novo CHUAC (New University Hospital of A Coruña), is one of the most ambitious public ...

Proman has named Anand Ragbir, former vice-president of Commercial and Finance at Atlantic LNG, as managing director of its ...

Greenland appointed its first Arctic ambassador on Friday, pledging to promote sustainable economic development for ...

The India launch of Eli Lilly's Mounjaro in India has triggered a huge wave of enquiries from those looking for its ...